Urosource: Conference Reports

Urosource Newsletter

Poll

Home > Conference Reports

Today's Key Article

Conference Reports

Circumcision protects against HIV over long term

Edited by: JV

Tuesday, 27 July 2010- Male circumcision appears to be protective against HIV for at least four and a half years, a researcher said during the International AIDS Conference (IAC) held in Vienna, Austria.

The finding from an observational follow-up to a major randomised trial initially conducted...

Interactive

EAU Barcelona Webcast

USC leads international programme aimed at identifying prostate cancer risk

Thursday, 22 July 2010- Researchers at the USC Norris Comprehensive Cancer Center have received a $12 million National Cancer Institute (NCI) grant to lead a multi-institution international project aimed at identifying new biological pathways critical to the development and potential treatment of...

Edited by: JV

Dutch study says finding cancer 'cold spots' can help reduce radiotherapy side-effects

Monday, 19 July 2010- Fine-tuning radiotherapy to take into account which parts of a patient's tumour are growing fastest could improve control of cancer while subjecting patients to lower doses of radiation, according to Dutch researchers.

"The only problem in radiotherapy is minimizing the...

Edited by: JV

More key articles

Clinical efficacy of alpha1-Adrenargic Receptor Antagonist in BPH patients

Wednesday, 28 July 2010- K. Kadekawa and colleagues assessed the clinical efficacy and safety of 75 mg/day of naftopidil, an alpha1-adrenargic receptor antagonist in patients with benign prostatic hyperplasia (BPH). They published their findings in the online edition of the journal LUTS:...

Outcome of patients with localised PCa treated by radiotherapy

Tuesday, 27 July 2010- N. Suzuki and colleagues conducted a study on the outcome of patients with localised prostate cancer who underwent radiotherapy after confirming the absence of lymph node invasion. They published their findings in the Japanese Journal of Clinical Oncology.

"Management...

More headline news

Stone size is the only predictor of ESWL success in children

Wednesday, 28 July 2010- S. McAdams and colleagues conducted a study to determine whether age, gender, body mass index, number of stones, stone location or total stone diameter could independently predict stone-free rates after extracorporeal shock wave lithotripsy in children.

They published...

African Americans face higher risk of kidney failure caused by hypertension

Tuesday, 27 July 2010- Regardless of demographics, African American patients with hypertensive nephrosclerosis have a higher rate of developing end stage renal disease (ESRD) than dying prematurely, according to a study appearing in an upcoming issue of the Journal of the American Society of...

More conference reports

New research model of prostate cancer growth shows role of sex hormones

Monday, 5 July 2010- Progress toward understanding the role of sex hormones in the growth of prostate cancer has been hindered by the lack of a suitable laboratory research model. Now US researchers say they have developed the first model of hormone-induced human prostate cancer initiation and...

Gout drug may decrease LVH in CKD patients

Thursday, 1 July 2010- Allopurinol, a drug long used to treat gout, can cause regression of left ventricular hypertrophy (LVH) and endothelial dysfunction in CKD patients, a study found.

The study is the first to show that allopurinol treatment is associated with these effects in CKD patients....

7th ESOU Meeting in Vienna to tackle emerging treatment options

Friday, 8 January 2010- Emerging treatment options that impact on the diagnosis of uro-genital cancers will be examined at the annual meeting of the EAU Section of Oncological Urology (ESOU) to be held in Vienna, Austria from January 15 to 17, 2010.

Prof. Bob Djavan, chairman of the 7th ESOU...

2nd EMUC to reach new heights of international cooperation

Thursday, 26 November 2009- Experts agree that the urological cancer patient will benefit greatly if the delivered treatment is a result of a combined effort. Collaboration of experts from various fields is, therefore, necessary to take cancer-related research and medical practice to the next...